HIV associated nephropathy cost-effectiveness of therapy: Difference between revisions
m (Changes made per Mahshid's request) |
No edit summary |
||
(5 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{HIV associated nephropathy}} | {{HIV associated nephropathy}} | ||
{{CMG}} {{AE}} {{SHA}} | |||
==Overview== | |||
The [[World Health Organization|World Health Organization (WHO)]] data on HIV/AIDS for 2018 is 37.9 million people living with HIV/AIDS worldwide and 770 000 deaths due to HIV-related illnesses worldwide.<ref name="urlWHO | HIV/AIDS" /> There is insufficient information about the cost-effectiveness of therapy in HIV associated nephropathy. | |||
==Cost-effectiveness of Therapy== | |||
*There is insufficient information about the cost-effectiveness of therapy in HIV associated nephropathy. | |||
*The [[World Health Organization|World Health Organization (WHO)]] data on HIV/AIDS is as the following for 2018:<ref name="urlWHO | HIV/AIDS">{{cite web |url=https://www.who.int/gho/hiv/en/ |title=WHO | HIV/AIDS |format= |work= |accessdate=}}</ref> | |||
**People living with HIV/AIDS: 37.9 million people living with HIV/AIDS worldwide in 2018 | |||
**Mortality: 770,000 people died of HIV-related illnesses worldwide in 2018 | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} |
Latest revision as of 07:47, 5 July 2020
HIV associated nephropathy Microchapters |
Differentiating HIV associated nephropathy from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
HIV associated nephropathy cost-effectiveness of therapy On the Web |
American Roentgen Ray Society Images of HIV associated nephropathy cost-effectiveness of therapy |
FDA on HIV associated nephropathy cost-effectiveness of therapy |
CDC on HIV associated nephropathy cost-effectiveness of therapy |
HIV associated nephropathy cost-effectiveness of therapy in the news |
Blogs on HIV associated nephropathy cost-effectiveness of therapy |
Risk calculators and risk factors for HIV associated nephropathy cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shakiba Hassanzadeh, MD[2]
Overview
The World Health Organization (WHO) data on HIV/AIDS for 2018 is 37.9 million people living with HIV/AIDS worldwide and 770 000 deaths due to HIV-related illnesses worldwide.[1] There is insufficient information about the cost-effectiveness of therapy in HIV associated nephropathy.
Cost-effectiveness of Therapy
- There is insufficient information about the cost-effectiveness of therapy in HIV associated nephropathy.
- The World Health Organization (WHO) data on HIV/AIDS is as the following for 2018:[1]
- People living with HIV/AIDS: 37.9 million people living with HIV/AIDS worldwide in 2018
- Mortality: 770,000 people died of HIV-related illnesses worldwide in 2018